Arrowhead Pharma ARWR reported its Q4 earnings results on Wednesday, November 29, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Arrowhead Pharma missed estimated earnings by 70.0%, reporting an EPS of $-1.02 versus an estimate of $-0.6.
Revenue was down $15.48 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.38 which was followed by a 10.78% drop in the share price the next day.
Here's a look at Arrowhead Pharma's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.58 | -0.64 | 0.44 | -0.16 |
EPS Actual | -0.96 | 0.45 | -0.39 | -0.81 |
Revenue Estimate | 48.19M | 45.48M | 162.52M | 50.44M |
Revenue Actual | 15.82M | 146.27M | 62.55M | 31.57M |
To track all earnings releases for Arrowhead Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.